Qube Research & Technologies (QRT)’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.24M Buy
1,714,544
+646,267
+60% +$2.35M 0.01% 1154
2025
Q1
$2.05M Sell
1,068,277
-123,082
-10% -$236K ﹤0.01% 1532
2024
Q4
$2.26M Sell
1,191,359
-132,370
-10% -$252K ﹤0.01% 1450
2024
Q3
$1.75M Sell
1,323,729
-420,887
-24% -$556K ﹤0.01% 1459
2024
Q2
$1.78M Sell
1,744,616
-518,060
-23% -$528K ﹤0.01% 1423
2024
Q1
$4.14M Buy
2,262,676
+2,005,503
+780% +$3.67M 0.01% 1153
2023
Q4
$319K Buy
257,173
+135,757
+112% +$168K ﹤0.01% 2197
2023
Q3
$138K Sell
121,416
-314,853
-72% -$359K ﹤0.01% 2130
2023
Q2
$399K Buy
+436,269
New +$399K ﹤0.01% 1502
2023
Q1
Sell
-14,855
Closed -$8.57K 2436
2022
Q4
$8.57K Sell
14,855
-194,900
-93% -$112K ﹤0.01% 2219
2022
Q3
$66K Sell
209,755
-388,624
-65% -$122K ﹤0.01% 2030
2022
Q2
$211K Buy
+598,379
New +$211K ﹤0.01% 1702
2021
Q3
Sell
-41,564
Closed -$158K 2148
2021
Q2
$158K Buy
+41,564
New +$158K ﹤0.01% 1843
2020
Q3
Sell
-21,616
Closed -$294K 1636
2020
Q2
$294K Buy
+21,616
New +$294K ﹤0.01% 1305